Literature DB >> 12191887

Dermal exposure to aqueous solutions of N-methyl pyrrolidone.

Peter Akrill1, John Cocker, Steve Dixon.   

Abstract

N-methyl pyrrolidone (NMP) is a substance widely used for its strong and selective solvent capacity. The strong potential NMP has for skin absorption makes biological monitoring ideal for exposure assessment. This study looked at brief exposures to NMP in aqueous solutions over a range of concentrations. Two volunteers placed one hand in NMP solutions ranging from 5 to 25% for as long as 15 min followed by urine collection for 48 h. The analyte of interest (analysed by GC-MS) was the NMP metabolite 5-hydroxy-N-methyl pyrrolidone (5-HNMP). Excretion of 5-HNMP was plotted against time and this showed that urine concentrations were at a maximum after about 10 h and 5-HNMP excretion continued for 48 h after exposure. The half-life of excretion was found to be approximately 11 h. The mean correlation between exposure (as a measure of exposure duration and solution concentration) and total 5-HNMP excreted was 0.9297.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12191887     DOI: 10.1016/s0378-4274(02)00175-3

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  5 in total

1.  Human volunteer study on the influence of exposure duration and dilution of dermally applied N-methyl-2-pyrrolidone (NMP) on the urinary elimination of NMP metabolites.

Authors:  Stephen A Keener; Renate Wrbitzky; Michael Bader
Journal:  Int Arch Occup Environ Health       Date:  2006-08-09       Impact factor: 3.015

2.  Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxicokinetics of NMP, 5-hydroxy- N-methyl-2-pyrrolidone, N-methylsuccinimide and 2-hydroxy- N-methylsuccinimide (2-HMSI), and biological monitoring using 2-HMSI as a biomarker.

Authors:  B A G Jönsson; B Akesson
Journal:  Int Arch Occup Environ Health       Date:  2003-04-03       Impact factor: 3.015

3.  Dermal absorption and urinary elimination of N-methyl-2-pyrrolidone.

Authors:  Michael Bader; Stephen A Keener; Renate Wrbitzky
Journal:  Int Arch Occup Environ Health       Date:  2005-10-12       Impact factor: 3.015

4.  Biological monitoring and health effects of low-level exposure to N-methyl-2-pyrrolidone: a cross-sectional study.

Authors:  Vincent Haufroid; Veronika K Jaeger; Stefan Jeggli; Rolf Eisenegger; Alfred Bernard; Drita Friedli; Dominique Lison; Philipp Hotz
Journal:  Int Arch Occup Environ Health       Date:  2014-08       Impact factor: 3.015

Review 5.  Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects.

Authors:  Johanna Hettinga; Robert Carlisle
Journal:  Vaccines (Basel)       Date:  2020-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.